NDC 61958-1901-1
Genvoya 150 mg/1
elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide · TABLET
Genvoya is a tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide at a strength of 150 mg/1. Manufactured by Gilead Sciences, Inc..
Key Facts
- Brand Name
- Genvoya
- Generic Name
- elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide
- NDC Code (Package)
61958-1901-1- NDC Code (Product)
61958-1901- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA207561
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
- Marketing Start
- 11/05/2015
Recall History
No Recall HistoryView Full Drug Page
Genvoya — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.